Pharmablock's convertible bonds face mandatory redemption, trading halt

Nanjing PharmaBlock Sciences Co., Ltd. has announced the impending mandatory redemption of its Yaoshi convertible bonds. The last day for trading will be September 12, 2025, after which the bonds will cease to trade. The final date for bondholders to convert their bonds into shares is September 17, 2025. After this date, any unconverted bonds will be compulsorily redeemed at RMB 100.62 per bond, which includes the par value and accrued interest.

The company is strongly advising bondholders to convert their bonds before the deadline to avoid potential investment losses, as the current secondary market price of Yaoshi bonds may differ significantly from the redemption price. To convert, investors must have an open GEM board trading account.

The redemption condition was triggered between July 25, 2025, and August 14, 2025, as PharmaBlock's A-share closing price was at least 130% of the current conversion price (RMB 43.69 per share) for 15 trading days. The issuer's funds are expected to arrive in the China Securities Depository and Clearing Corporation's account by September 23, 2025, with investor redemption funds reaching accounts by September 25, 2025.